1
项与 Claudin18.2-Targeted CAR-T Cell(Gracell Bioscience) 相关的临床试验An Early Exploratory Clinical Trial of Claudin18.2-Targeted Chimeric Antigen Receptor T Cell Therapy for Gastric/Gastroesophageal Junction Adenocarcinoma.
A single-arm, open-label early-stage exploratory clinical study to evaluate the safety, tolerability and efficacy of Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in subjects with gastric/gastroesophageal junction adenocarcinoma.
100 项与 Claudin18.2-Targeted CAR-T Cell(Gracell Bioscience) 相关的临床结果
100 项与 Claudin18.2-Targeted CAR-T Cell(Gracell Bioscience) 相关的转化医学
100 项与 Claudin18.2-Targeted CAR-T Cell(Gracell Bioscience) 相关的专利(医药)
100 项与 Claudin18.2-Targeted CAR-T Cell(Gracell Bioscience) 相关的药物交易